LOUISBOURG INVESTMENTS INC.

Position in CRSP — CRISPR Therapeutics AG

CIK 2053050 DIEPPE, A3

Position in CRSP

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$4,363

+$558 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#432

of 519 holders

Holding Since

Jun 2025

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

LOUISBOURG INVESTMENTS INC. holds $41,332 across 5 Biotechnology names. CRSP ranks #2 (10.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	502	$28,147
2	CRSP	CRISPR Therapeutics AG This page	80	$4,363
3	NTLA	Intellia Therapeutics, Inc.	200	$3,384
4	VRTX	Vertex Pharmaceuticals Inc / Ma	6	$2,980
5	RXRX	Recursion Pharmaceuticals, Inc.	670	$2,458

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,363	80	0.0%	Shares	Sole	2026-07-23
2026-03-31	$3,805	80	0.0%	Shares	Sole	2026-04-22
2025-12-31	$4,195	80	+33.3%	Shares	Sole	2026-01-16
2025-09-30	$3,888	60	0.0%	Shares	Sole	2025-10-09
2025-06-30	$2,918	60	—	Shares	Sole	2025-07-24
No filing history on record for this holder in this stock.